FIELD: organic chemistry, chemical technology, medicine.
SUBSTANCE: invention relates to novel biologically active chemical compounds, namely, to 2-methyl-3-hydroxy-4-formyl-5-hydroxypyridine β-hydroxynicotinoyl hydrazone dihydrochloride of the general formula (I): that possesses antioxidant, hepatoprotecting and immunomodulating effect. Compound of the formula (I) is synthesized by interaction of 5-hydroxynicotinic acid hydrazide with 2-methyl-3-hydroxy-4-formyl-5-hydroxypyridine hydrochloride at heating in the presence of a solvent and hydrochloric acid. Compound of the formula (I) induces the expressed stimulation of humoral response in rats. Mexidol as the known antioxidant doesn't possess such activity. By effect on the hypersensitivity response of delayed type compound of the formula (I) elicits the equal activity with mexidol. Compound of the formula (I) eliminates immunosuppressing effect arising in experimental acute pancreatitis and immunostimulation induced by administration of CCl4 and it exceeds mexidol by its immunomodulating, antioxidant and hepatoprotecting effect in proposed models.
EFFECT: valuable medicinal properties of compound.
1 cl, 6 tbl, 1 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD OF PREPARING ERYTHROCYTE FOR STIMULATION OF IMMUNOLOGICAL REACTIVITY IN LABORATORY ANIMALS | 2000 |
|
RU2157702C1 |
AGENT HAVING ADAPTOGENIC AND IMMUNOMODULATING ACTIVITY | 2013 |
|
RU2516886C1 |
IMMUNOMODULATOR | 2003 |
|
RU2253447C1 |
METHOD OF TOXIC LIVER DAMAGE REDUCTION | 2007 |
|
RU2342132C2 |
IMMUNOMODULATOR | 2003 |
|
RU2253444C1 |
METHOD FOR OBTAINING AN AGENT WITH NEUROPROTECTIVE, IMMUNOMODULATORY ACTIVITY | 2022 |
|
RU2784435C1 |
METHOD FOR OBTAINING A DRUG WITH IMMUNOMODULATORY ACTIVITY | 2021 |
|
RU2797119C2 |
IMMUNOMODULATING AGENT | 2003 |
|
RU2245142C1 |
METHOD FOR PREPARING ERYTHROCYTES FOR STIMULATING BIOLOGICAL ACTIVITY | 1996 |
|
RU2114433C1 |
METHOD FOR STIMULATING IMMUNOLOGICAL REACTIVITY IN LABORATORY ANIMALS | 1995 |
|
RU2084896C1 |
Authors
Dates
2007-08-10—Published
2006-02-17—Filed